1. Home
  2. TECX vs ACNB Comparison

TECX vs ACNB Comparison

Compare TECX & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • ACNB
  • Stock Information
  • Founded
  • TECX 2019
  • ACNB 1857
  • Country
  • TECX United States
  • ACNB United States
  • Employees
  • TECX N/A
  • ACNB N/A
  • Industry
  • TECX
  • ACNB Major Banks
  • Sector
  • TECX
  • ACNB Finance
  • Exchange
  • TECX Nasdaq
  • ACNB Nasdaq
  • Market Cap
  • TECX 387.1M
  • ACNB 450.1M
  • IPO Year
  • TECX 2018
  • ACNB N/A
  • Fundamental
  • Price
  • TECX $23.51
  • ACNB $44.11
  • Analyst Decision
  • TECX Strong Buy
  • ACNB Strong Buy
  • Analyst Count
  • TECX 5
  • ACNB 3
  • Target Price
  • TECX $79.00
  • ACNB $50.00
  • AVG Volume (30 Days)
  • TECX 230.2K
  • ACNB 20.2K
  • Earning Date
  • TECX 08-07-2025
  • ACNB 07-24-2025
  • Dividend Yield
  • TECX N/A
  • ACNB 3.06%
  • EPS Growth
  • TECX N/A
  • ACNB N/A
  • EPS
  • TECX N/A
  • ACNB 2.69
  • Revenue
  • TECX N/A
  • ACNB $123,053,000.00
  • Revenue This Year
  • TECX N/A
  • ACNB $40.18
  • Revenue Next Year
  • TECX N/A
  • ACNB $4.83
  • P/E Ratio
  • TECX N/A
  • ACNB $16.53
  • Revenue Growth
  • TECX N/A
  • ACNB 15.31
  • 52 Week Low
  • TECX $13.70
  • ACNB $35.70
  • 52 Week High
  • TECX $61.07
  • ACNB $50.72
  • Technical
  • Relative Strength Index (RSI)
  • TECX 56.50
  • ACNB 56.97
  • Support Level
  • TECX $21.31
  • ACNB $42.10
  • Resistance Level
  • TECX $23.12
  • ACNB $45.59
  • Average True Range (ATR)
  • TECX 1.53
  • ACNB 0.94
  • MACD
  • TECX 0.13
  • ACNB 0.28
  • Stochastic Oscillator
  • TECX 71.85
  • ACNB 69.10

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

Share on Social Networks: